TrialGynecologic oncology2017

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.

Martee L Hensley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.